Literature DB >> 8383779

Replicative viral DNA in Epstein-Barr virus associated Burkitt's lymphoma biopsies.

M I Gutierrez1, K Bhatia, I Magrath.   

Abstract

Epstein-Barr virus (EBV) is linked to a spectrum of human diseases including epithelial and lymphoid malignancies in which it exists predominantly in a latent state. EBV is capable of establishing replicative infection at oropharyngeal and genital sites. Replicative EBV infection also occurs in oral hairy leukoplakia, in EBV associated lymphoproliferative disorders, and to a minor degree in nasopharyngeal carcinomas. Recent evidence also suggests that EBV replication, also, may be associated with AIDS related lymphomas and Hodgkin's disease. However it is widely believed that virus in circulating B-lymphocytes and in B-cell malignancies is stringently latent. We now show that by Southern blot analysis we can detect replicative forms of virion DNA in 14.5% (8 of 55) of EBV-positive Burkitt's lymphoma biopsies. This may be the explanation for the elevation of the titres of lytic cycle EBV antigens that is associated with presentation and relapse of EBV associated Burkitt's lymphoma.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8383779     DOI: 10.1016/0145-2126(93)90013-b

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  5 in total

1.  Matrix metalloproteinase 9 is induced by the Epstein-Barr virus BZLF1 transactivator.

Authors:  T Yoshizaki; H Sato; S Murono; J S Pagano; M Furukawa
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

2.  Activity of the EBNA1 promoter associated with lytic replication (Fp) in Epstein-Barr virus associated disorders.

Authors:  A A Brink; C J Meijer; J M Nicholls; J M Middeldorp; A J van den Brule
Journal:  Mol Pathol       Date:  2001-04

Review 3.  Detection and characterization of Epstein-Barr virus in clinical specimens.

Authors:  R F Ambinder; R B Mann
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

4.  Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders.

Authors:  D T Rowe; L Qu; J Reyes; N Jabbour; E Yunis; P Putnam; S Todo; M Green
Journal:  J Clin Microbiol       Date:  1997-06       Impact factor: 5.948

5.  Lymphoepithelial carcinoma of the salivary gland: in situ detection of Epstein-Barr virus.

Authors:  S Y Leung; L P Chung; S T Yuen; C M Ho; M P Wong; S Y Chan
Journal:  J Clin Pathol       Date:  1995-11       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.